Neumora Therapeutics

North America Legal Chronicle. September 26, 2023

Neumora Therapeutics’ $250.1 Million Initial Public Offering

By Pietro Martinoia

Latham & Watkins advised Neumora, and Cooley advised the underwriters. Neumora Therapeutics, Inc. announced the pricing of its initial public offering of 14,710,000 shares of its common...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

North America Legal Chronicle. October 21, 2021

Neumora Therapeutics’ Collaboration With Amgen

By Laura Testa

Latham & Watkins represented Neumora in the deal. Amgen and Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering precision medicines for brain diseases, announced a strategic collaboration...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

BC Partners Credit’s Acquisition of Runway Growth Capital

PBT Bancshares’ Acquisition of KANZA Bank

Nuvo’s Chapter 11 Bankruptcy Filing

Reddy Ice’s Acquisition of Aguafría

‘Mercado Crédito XXVII’ Financial Trusts’ Issuance

Crescera Capital’s Acquisition of Segware

Global Infrastructure Partners (BlackRock)’s Investment In Lanes Group

M Group’s Acquisition Of BGEN Ltd

Airbus Defence and Space’s Lease Agreement For Three UHF TACSAT Satellite Channels

Camusat Holding’s €81 Million Mezzanine Investment Round

Retail Holding’s Shareholders Reconfiguration

Ora Developers Egypt for Real Estate Investment’s Financing Round

Fourth Milling Company’s Initial Public Offering on Tadawul

A101 Yeni Magazacilik A.S.’ $200 Million Sustainability Loan

ADNH Catering’s US$235 Million Initial Public Offering

Akasa Air’s Partnership with Rolls-Royce for Engine Leasing

OUE Treasury’s Green Bond Offering

Sembcorp Industries’ Notes Issuance

Senior M&A Lawyer Deepa Vallabh Joins Bowmans in Johannesburg

Michael R. Guerrero Returns to Hinshaw’s Consumer Financial Services Group in California

James Barbaria Joins Hinshaw & Culbertson LLP as Chief Financial Officer

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Senior M&A Lawyer Deepa Vallabh Joins Bowmans in Johannesburg

Michael R. Guerrero Returns to Hinshaw’s Consumer Financial Services Group in California

James Barbaria Joins Hinshaw & Culbertson LLP as Chief Financial Officer

Neumora Therapeutics’ $250.1 Million Initial Public Offering

Standard 1 Year Membership Required

Neumora Therapeutics’ Collaboration With Amgen

Standard 1 Year Membership Required